nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefoxitin—Agranulocytosis—Thiotepa—urinary bladder cancer	0.00413	0.00413	CcSEcCtD
Cefoxitin—Eosinophilia—Fluorouracil—urinary bladder cancer	0.00407	0.00407	CcSEcCtD
Cefoxitin—Haemoglobin—Thiotepa—urinary bladder cancer	0.004	0.004	CcSEcCtD
Cefoxitin—Haemorrhage—Thiotepa—urinary bladder cancer	0.00398	0.00398	CcSEcCtD
Cefoxitin—Pancytopenia—Gemcitabine—urinary bladder cancer	0.00397	0.00397	CcSEcCtD
Cefoxitin—Urinary tract disorder—Thiotepa—urinary bladder cancer	0.00393	0.00393	CcSEcCtD
Cefoxitin—Neutropenia—Gemcitabine—urinary bladder cancer	0.00391	0.00391	CcSEcCtD
Cefoxitin—Pancytopenia—Fluorouracil—urinary bladder cancer	0.0039	0.0039	CcSEcCtD
Cefoxitin—Urethral disorder—Thiotepa—urinary bladder cancer	0.0039	0.0039	CcSEcCtD
Cefoxitin—Diarrhoea—Mitomycin—urinary bladder cancer	0.00384	0.00384	CcSEcCtD
Cefoxitin—Toxic epidermal necrolysis—Etoposide—urinary bladder cancer	0.00372	0.00372	CcSEcCtD
Cefoxitin—Pancytopenia—Cisplatin—urinary bladder cancer	0.0037	0.0037	CcSEcCtD
Cefoxitin—Stevens-Johnson syndrome—Gemcitabine—urinary bladder cancer	0.00369	0.00369	CcSEcCtD
Cefoxitin—Vomiting—Mitomycin—urinary bladder cancer	0.00357	0.00357	CcSEcCtD
Cefoxitin—Rash—Mitomycin—urinary bladder cancer	0.00354	0.00354	CcSEcCtD
Cefoxitin—Dermatitis—Mitomycin—urinary bladder cancer	0.00354	0.00354	CcSEcCtD
Cefoxitin—Agranulocytosis—Gemcitabine—urinary bladder cancer	0.00348	0.00348	CcSEcCtD
Cefoxitin—Erythema—Thiotepa—urinary bladder cancer	0.00346	0.00346	CcSEcCtD
Cefoxitin—Agranulocytosis—Fluorouracil—urinary bladder cancer	0.00342	0.00342	CcSEcCtD
Cefoxitin—Vaginal inflammation—Methotrexate—urinary bladder cancer	0.00341	0.00341	CcSEcCtD
Cefoxitin—Pancytopenia—Etoposide—urinary bladder cancer	0.00339	0.00339	CcSEcCtD
Cefoxitin—Blood bilirubin increased—Epirubicin—urinary bladder cancer	0.00337	0.00337	CcSEcCtD
Cefoxitin—Haemoglobin—Gemcitabine—urinary bladder cancer	0.00336	0.00336	CcSEcCtD
Cefoxitin—Haemorrhage—Gemcitabine—urinary bladder cancer	0.00334	0.00334	CcSEcCtD
Cefoxitin—Neutropenia—Etoposide—urinary bladder cancer	0.00334	0.00334	CcSEcCtD
Cefoxitin—Nausea—Mitomycin—urinary bladder cancer	0.00334	0.00334	CcSEcCtD
Cefoxitin—Haemoglobin—Fluorouracil—urinary bladder cancer	0.00331	0.00331	CcSEcCtD
Cefoxitin—Urinary tract disorder—Gemcitabine—urinary bladder cancer	0.0033	0.0033	CcSEcCtD
Cefoxitin—Haemorrhage—Fluorouracil—urinary bladder cancer	0.00329	0.00329	CcSEcCtD
Cefoxitin—Urethral disorder—Gemcitabine—urinary bladder cancer	0.00328	0.00328	CcSEcCtD
Cefoxitin—Vaginal infection—Methotrexate—urinary bladder cancer	0.00322	0.00322	CcSEcCtD
Cefoxitin—Anaemia—Thiotepa—urinary bladder cancer	0.0032	0.0032	CcSEcCtD
Cefoxitin—Aplastic anaemia—Methotrexate—urinary bladder cancer	0.0032	0.0032	CcSEcCtD
Cefoxitin—Vaginal inflammation—Epirubicin—urinary bladder cancer	0.00319	0.00319	CcSEcCtD
Cefoxitin—Erythema multiforme—Gemcitabine—urinary bladder cancer	0.00316	0.00316	CcSEcCtD
Cefoxitin—Stevens-Johnson syndrome—Etoposide—urinary bladder cancer	0.00315	0.00315	CcSEcCtD
Cefoxitin—Blood bilirubin increased—Doxorubicin—urinary bladder cancer	0.00312	0.00312	CcSEcCtD
Cefoxitin—Jaundice—Etoposide—urinary bladder cancer	0.0031	0.0031	CcSEcCtD
Cefoxitin—Leukopenia—Thiotepa—urinary bladder cancer	0.0031	0.0031	CcSEcCtD
Cefoxitin—Urinary tract disorder—Cisplatin—urinary bladder cancer	0.00308	0.00308	CcSEcCtD
Cefoxitin—Colitis—Epirubicin—urinary bladder cancer	0.00306	0.00306	CcSEcCtD
Cefoxitin—Urethral disorder—Cisplatin—urinary bladder cancer	0.00306	0.00306	CcSEcCtD
Cefoxitin—Candida infection—Epirubicin—urinary bladder cancer	0.00304	0.00304	CcSEcCtD
Cefoxitin—Vaginal infection—Epirubicin—urinary bladder cancer	0.00301	0.00301	CcSEcCtD
Cefoxitin—Convulsion—Thiotepa—urinary bladder cancer	0.003	0.003	CcSEcCtD
Cefoxitin—Aplastic anaemia—Epirubicin—urinary bladder cancer	0.00299	0.00299	CcSEcCtD
Cefoxitin—Agranulocytosis—Etoposide—urinary bladder cancer	0.00297	0.00297	CcSEcCtD
Cefoxitin—Vaginal inflammation—Doxorubicin—urinary bladder cancer	0.00295	0.00295	CcSEcCtD
Cefoxitin—Erythema—Gemcitabine—urinary bladder cancer	0.00291	0.00291	CcSEcCtD
Cefoxitin—Rash maculo-papular—Epirubicin—urinary bladder cancer	0.0029	0.0029	CcSEcCtD
Cefoxitin—Flushing—Cisplatin—urinary bladder cancer	0.00289	0.00289	CcSEcCtD
Cefoxitin—Erythema—Fluorouracil—urinary bladder cancer	0.00286	0.00286	CcSEcCtD
Cefoxitin—Thrombophlebitis—Methotrexate—urinary bladder cancer	0.00286	0.00286	CcSEcCtD
Cefoxitin—Colitis—Doxorubicin—urinary bladder cancer	0.00283	0.00283	CcSEcCtD
Cefoxitin—Urinary tract disorder—Etoposide—urinary bladder cancer	0.00282	0.00282	CcSEcCtD
Cefoxitin—Candida infection—Doxorubicin—urinary bladder cancer	0.00282	0.00282	CcSEcCtD
Cefoxitin—Urethral disorder—Etoposide—urinary bladder cancer	0.0028	0.0028	CcSEcCtD
Cefoxitin—Vaginal infection—Doxorubicin—urinary bladder cancer	0.00278	0.00278	CcSEcCtD
Cefoxitin—Aplastic anaemia—Doxorubicin—urinary bladder cancer	0.00277	0.00277	CcSEcCtD
Cefoxitin—Thrombocytopenia—Thiotepa—urinary bladder cancer	0.00277	0.00277	CcSEcCtD
Cefoxitin—Erythema—Cisplatin—urinary bladder cancer	0.00271	0.00271	CcSEcCtD
Cefoxitin—Erythema multiforme—Etoposide—urinary bladder cancer	0.0027	0.0027	CcSEcCtD
Cefoxitin—Anaemia—Gemcitabine—urinary bladder cancer	0.00269	0.00269	CcSEcCtD
Cefoxitin—Phlebitis—Epirubicin—urinary bladder cancer	0.00269	0.00269	CcSEcCtD
Cefoxitin—Rash maculo-papular—Doxorubicin—urinary bladder cancer	0.00268	0.00268	CcSEcCtD
Cefoxitin—Renal failure acute—Methotrexate—urinary bladder cancer	0.00268	0.00268	CcSEcCtD
Cefoxitin—Thrombophlebitis—Epirubicin—urinary bladder cancer	0.00267	0.00267	CcSEcCtD
Cefoxitin—Flushing—Etoposide—urinary bladder cancer	0.00265	0.00265	CcSEcCtD
Cefoxitin—Hepatic function abnormal—Epirubicin—urinary bladder cancer	0.00265	0.00265	CcSEcCtD
Cefoxitin—Anaemia—Fluorouracil—urinary bladder cancer	0.00265	0.00265	CcSEcCtD
Cefoxitin—Dermatitis exfoliative—Methotrexate—urinary bladder cancer	0.00262	0.00262	CcSEcCtD
Cefoxitin—Leukopenia—Gemcitabine—urinary bladder cancer	0.00261	0.00261	CcSEcCtD
Cefoxitin—Leukopenia—Fluorouracil—urinary bladder cancer	0.00256	0.00256	CcSEcCtD
Cefoxitin—Anaemia—Cisplatin—urinary bladder cancer	0.00251	0.00251	CcSEcCtD
Cefoxitin—Renal failure acute—Epirubicin—urinary bladder cancer	0.00251	0.00251	CcSEcCtD
Cefoxitin—Phlebitis—Doxorubicin—urinary bladder cancer	0.00249	0.00249	CcSEcCtD
Cefoxitin—Convulsion—Fluorouracil—urinary bladder cancer	0.00248	0.00248	CcSEcCtD
Cefoxitin—Thrombophlebitis—Doxorubicin—urinary bladder cancer	0.00247	0.00247	CcSEcCtD
Cefoxitin—Dermatitis exfoliative—Epirubicin—urinary bladder cancer	0.00245	0.00245	CcSEcCtD
Cefoxitin—Hepatic function abnormal—Doxorubicin—urinary bladder cancer	0.00245	0.00245	CcSEcCtD
Cefoxitin—Leukopenia—Cisplatin—urinary bladder cancer	0.00243	0.00243	CcSEcCtD
Cefoxitin—Pain—Thiotepa—urinary bladder cancer	0.00242	0.00242	CcSEcCtD
Cefoxitin—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.00238	0.00238	CcSEcCtD
Cefoxitin—Convulsion—Cisplatin—urinary bladder cancer	0.00235	0.00235	CcSEcCtD
Cefoxitin—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.00234	0.00234	CcSEcCtD
Cefoxitin—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.00233	0.00233	CcSEcCtD
Cefoxitin—Renal failure acute—Doxorubicin—urinary bladder cancer	0.00232	0.00232	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.00231	0.00231	CcSEcCtD
Cefoxitin—Anaemia—Etoposide—urinary bladder cancer	0.0023	0.0023	CcSEcCtD
Cefoxitin—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.00229	0.00229	CcSEcCtD
Cefoxitin—Dermatitis exfoliative—Doxorubicin—urinary bladder cancer	0.00227	0.00227	CcSEcCtD
Cefoxitin—Urticaria—Thiotepa—urinary bladder cancer	0.00224	0.00224	CcSEcCtD
Cefoxitin—Abdominal pain—Thiotepa—urinary bladder cancer	0.00223	0.00223	CcSEcCtD
Cefoxitin—Body temperature increased—Thiotepa—urinary bladder cancer	0.00223	0.00223	CcSEcCtD
Cefoxitin—Toxic epidermal necrolysis—Methotrexate—urinary bladder cancer	0.00223	0.00223	CcSEcCtD
Cefoxitin—Leukopenia—Etoposide—urinary bladder cancer	0.00223	0.00223	CcSEcCtD
Cefoxitin—Hypotension—Gemcitabine—urinary bladder cancer	0.00222	0.00222	CcSEcCtD
Cefoxitin—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.00221	0.00221	CcSEcCtD
Cefoxitin—Hypotension—Fluorouracil—urinary bladder cancer	0.00218	0.00218	CcSEcCtD
Cefoxitin—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.00217	0.00217	CcSEcCtD
Cefoxitin—Convulsion—Etoposide—urinary bladder cancer	0.00215	0.00215	CcSEcCtD
Cefoxitin—Dyspnoea—Gemcitabine—urinary bladder cancer	0.00212	0.00212	CcSEcCtD
Cefoxitin—Eosinophilia—Methotrexate—urinary bladder cancer	0.00212	0.00212	CcSEcCtD
Cefoxitin—Toxic epidermal necrolysis—Epirubicin—urinary bladder cancer	0.00208	0.00208	CcSEcCtD
Cefoxitin—Dyspnoea—Fluorouracil—urinary bladder cancer	0.00208	0.00208	CcSEcCtD
Cefoxitin—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00208	0.00208	CcSEcCtD
Cefoxitin—Hypotension—Cisplatin—urinary bladder cancer	0.00207	0.00207	CcSEcCtD
Cefoxitin—Pain—Gemcitabine—urinary bladder cancer	0.00203	0.00203	CcSEcCtD
Cefoxitin—Pancytopenia—Methotrexate—urinary bladder cancer	0.00203	0.00203	CcSEcCtD
Cefoxitin—Anaphylactic shock—Etoposide—urinary bladder cancer	0.00203	0.00203	CcSEcCtD
Cefoxitin—Neutropenia—Methotrexate—urinary bladder cancer	0.002	0.002	CcSEcCtD
Cefoxitin—Pruritus—Thiotepa—urinary bladder cancer	0.002	0.002	CcSEcCtD
Cefoxitin—Pain—Fluorouracil—urinary bladder cancer	0.002	0.002	CcSEcCtD
Cefoxitin—Thrombocytopenia—Etoposide—urinary bladder cancer	0.00199	0.00199	CcSEcCtD
Cefoxitin—Eosinophilia—Epirubicin—urinary bladder cancer	0.00198	0.00198	CcSEcCtD
Cefoxitin—Dyspnoea—Cisplatin—urinary bladder cancer	0.00197	0.00197	CcSEcCtD
Cefoxitin—Diarrhoea—Thiotepa—urinary bladder cancer	0.00193	0.00193	CcSEcCtD
Cefoxitin—Toxic epidermal necrolysis—Doxorubicin—urinary bladder cancer	0.00193	0.00193	CcSEcCtD
Cefoxitin—Pancytopenia—Epirubicin—urinary bladder cancer	0.0019	0.0019	CcSEcCtD
Cefoxitin—Hypotension—Etoposide—urinary bladder cancer	0.0019	0.0019	CcSEcCtD
Cefoxitin—Pain—Cisplatin—urinary bladder cancer	0.00189	0.00189	CcSEcCtD
Cefoxitin—Stevens-Johnson syndrome—Methotrexate—urinary bladder cancer	0.00189	0.00189	CcSEcCtD
Cefoxitin—Body temperature increased—Gemcitabine—urinary bladder cancer	0.00188	0.00188	CcSEcCtD
Cefoxitin—Neutropenia—Epirubicin—urinary bladder cancer	0.00187	0.00187	CcSEcCtD
Cefoxitin—Urticaria—Fluorouracil—urinary bladder cancer	0.00186	0.00186	CcSEcCtD
Cefoxitin—Body temperature increased—Fluorouracil—urinary bladder cancer	0.00185	0.00185	CcSEcCtD
Cefoxitin—Eosinophilia—Doxorubicin—urinary bladder cancer	0.00183	0.00183	CcSEcCtD
Cefoxitin—Dyspnoea—Etoposide—urinary bladder cancer	0.00181	0.00181	CcSEcCtD
Cefoxitin—Vomiting—Thiotepa—urinary bladder cancer	0.0018	0.0018	CcSEcCtD
Cefoxitin—Rash—Thiotepa—urinary bladder cancer	0.00178	0.00178	CcSEcCtD
Cefoxitin—Dermatitis—Thiotepa—urinary bladder cancer	0.00178	0.00178	CcSEcCtD
Cefoxitin—Agranulocytosis—Methotrexate—urinary bladder cancer	0.00178	0.00178	CcSEcCtD
Cefoxitin—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	0.00177	0.00177	CcSEcCtD
Cefoxitin—Pancytopenia—Doxorubicin—urinary bladder cancer	0.00176	0.00176	CcSEcCtD
Cefoxitin—Body temperature increased—Cisplatin—urinary bladder cancer	0.00175	0.00175	CcSEcCtD
Cefoxitin—Jaundice—Epirubicin—urinary bladder cancer	0.00174	0.00174	CcSEcCtD
Cefoxitin—Pain—Etoposide—urinary bladder cancer	0.00174	0.00174	CcSEcCtD
Cefoxitin—Neutropenia—Doxorubicin—urinary bladder cancer	0.00173	0.00173	CcSEcCtD
Cefoxitin—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.00172	0.00172	CcSEcCtD
Cefoxitin—Haemoglobin—Methotrexate—urinary bladder cancer	0.00172	0.00172	CcSEcCtD
Cefoxitin—Haemorrhage—Methotrexate—urinary bladder cancer	0.00171	0.00171	CcSEcCtD
Cefoxitin—Urinary tract disorder—Methotrexate—urinary bladder cancer	0.00169	0.00169	CcSEcCtD
Cefoxitin—Pruritus—Gemcitabine—urinary bladder cancer	0.00168	0.00168	CcSEcCtD
Cefoxitin—Nausea—Thiotepa—urinary bladder cancer	0.00168	0.00168	CcSEcCtD
Cefoxitin—Urethral disorder—Methotrexate—urinary bladder cancer	0.00168	0.00168	CcSEcCtD
Cefoxitin—Agranulocytosis—Epirubicin—urinary bladder cancer	0.00166	0.00166	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.00166	0.00166	CcSEcCtD
Cefoxitin—Pruritus—Fluorouracil—urinary bladder cancer	0.00165	0.00165	CcSEcCtD
Cefoxitin—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.00164	0.00164	CcSEcCtD
Cefoxitin—Hypersensitivity—Cisplatin—urinary bladder cancer	0.00163	0.00163	CcSEcCtD
Cefoxitin—Diarrhoea—Gemcitabine—urinary bladder cancer	0.00163	0.00163	CcSEcCtD
Cefoxitin—Erythema multiforme—Methotrexate—urinary bladder cancer	0.00162	0.00162	CcSEcCtD
Cefoxitin—Urticaria—Etoposide—urinary bladder cancer	0.00161	0.00161	CcSEcCtD
Cefoxitin—Haemoglobin—Epirubicin—urinary bladder cancer	0.00161	0.00161	CcSEcCtD
Cefoxitin—Jaundice—Doxorubicin—urinary bladder cancer	0.00161	0.00161	CcSEcCtD
Cefoxitin—Abdominal pain—Etoposide—urinary bladder cancer	0.0016	0.0016	CcSEcCtD
Cefoxitin—Body temperature increased—Etoposide—urinary bladder cancer	0.0016	0.0016	CcSEcCtD
Cefoxitin—Haemorrhage—Epirubicin—urinary bladder cancer	0.0016	0.0016	CcSEcCtD
Cefoxitin—Diarrhoea—Fluorouracil—urinary bladder cancer	0.0016	0.0016	CcSEcCtD
Cefoxitin—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.00158	0.00158	CcSEcCtD
Cefoxitin—Urethral disorder—Epirubicin—urinary bladder cancer	0.00157	0.00157	CcSEcCtD
Cefoxitin—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.00154	0.00154	CcSEcCtD
Cefoxitin—Diarrhoea—Cisplatin—urinary bladder cancer	0.00152	0.00152	CcSEcCtD
Cefoxitin—Erythema multiforme—Epirubicin—urinary bladder cancer	0.00151	0.00151	CcSEcCtD
Cefoxitin—Vomiting—Gemcitabine—urinary bladder cancer	0.00151	0.00151	CcSEcCtD
Cefoxitin—Rash—Gemcitabine—urinary bladder cancer	0.0015	0.0015	CcSEcCtD
Cefoxitin—Dermatitis—Gemcitabine—urinary bladder cancer	0.0015	0.0015	CcSEcCtD
Cefoxitin—Hypersensitivity—Etoposide—urinary bladder cancer	0.0015	0.0015	CcSEcCtD
Cefoxitin—Erythema—Methotrexate—urinary bladder cancer	0.00149	0.00149	CcSEcCtD
Cefoxitin—Haemoglobin—Doxorubicin—urinary bladder cancer	0.00149	0.00149	CcSEcCtD
Cefoxitin—Flushing—Epirubicin—urinary bladder cancer	0.00149	0.00149	CcSEcCtD
Cefoxitin—Vomiting—Fluorouracil—urinary bladder cancer	0.00149	0.00149	CcSEcCtD
Cefoxitin—Haemorrhage—Doxorubicin—urinary bladder cancer	0.00148	0.00148	CcSEcCtD
Cefoxitin—Rash—Fluorouracil—urinary bladder cancer	0.00147	0.00147	CcSEcCtD
Cefoxitin—Dermatitis—Fluorouracil—urinary bladder cancer	0.00147	0.00147	CcSEcCtD
Cefoxitin—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.00146	0.00146	CcSEcCtD
Cefoxitin—Urethral disorder—Doxorubicin—urinary bladder cancer	0.00145	0.00145	CcSEcCtD
Cefoxitin—Pruritus—Etoposide—urinary bladder cancer	0.00144	0.00144	CcSEcCtD
Cefoxitin—Nausea—Gemcitabine—urinary bladder cancer	0.00141	0.00141	CcSEcCtD
Cefoxitin—Vomiting—Cisplatin—urinary bladder cancer	0.00141	0.00141	CcSEcCtD
Cefoxitin—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.0014	0.0014	CcSEcCtD
Cefoxitin—Rash—Cisplatin—urinary bladder cancer	0.0014	0.0014	CcSEcCtD
Cefoxitin—Dermatitis—Cisplatin—urinary bladder cancer	0.0014	0.0014	CcSEcCtD
Cefoxitin—Erythema—Epirubicin—urinary bladder cancer	0.00139	0.00139	CcSEcCtD
Cefoxitin—Diarrhoea—Etoposide—urinary bladder cancer	0.00139	0.00139	CcSEcCtD
Cefoxitin—Nausea—Fluorouracil—urinary bladder cancer	0.00139	0.00139	CcSEcCtD
Cefoxitin—Anaemia—Methotrexate—urinary bladder cancer	0.00138	0.00138	CcSEcCtD
Cefoxitin—Flushing—Doxorubicin—urinary bladder cancer	0.00137	0.00137	CcSEcCtD
Cefoxitin—Leukopenia—Methotrexate—urinary bladder cancer	0.00133	0.00133	CcSEcCtD
Cefoxitin—Nausea—Cisplatin—urinary bladder cancer	0.00132	0.00132	CcSEcCtD
Cefoxitin—Convulsion—Methotrexate—urinary bladder cancer	0.00129	0.00129	CcSEcCtD
Cefoxitin—Vomiting—Etoposide—urinary bladder cancer	0.00129	0.00129	CcSEcCtD
Cefoxitin—Erythema—Doxorubicin—urinary bladder cancer	0.00129	0.00129	CcSEcCtD
Cefoxitin—Anaemia—Epirubicin—urinary bladder cancer	0.00129	0.00129	CcSEcCtD
Cefoxitin—Rash—Etoposide—urinary bladder cancer	0.00128	0.00128	CcSEcCtD
Cefoxitin—Dermatitis—Etoposide—urinary bladder cancer	0.00128	0.00128	CcSEcCtD
Cefoxitin—Leukopenia—Epirubicin—urinary bladder cancer	0.00125	0.00125	CcSEcCtD
Cefoxitin—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.00122	0.00122	CcSEcCtD
Cefoxitin—Convulsion—Epirubicin—urinary bladder cancer	0.00121	0.00121	CcSEcCtD
Cefoxitin—Nausea—Etoposide—urinary bladder cancer	0.00121	0.00121	CcSEcCtD
Cefoxitin—Anaemia—Doxorubicin—urinary bladder cancer	0.00119	0.00119	CcSEcCtD
Cefoxitin—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.00119	0.00119	CcSEcCtD
Cefoxitin—Leukopenia—Doxorubicin—urinary bladder cancer	0.00115	0.00115	CcSEcCtD
Cefoxitin—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.00114	0.00114	CcSEcCtD
Cefoxitin—Hypotension—Methotrexate—urinary bladder cancer	0.00114	0.00114	CcSEcCtD
Cefoxitin—Convulsion—Doxorubicin—urinary bladder cancer	0.00112	0.00112	CcSEcCtD
Cefoxitin—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.00111	0.00111	CcSEcCtD
Cefoxitin—Dyspnoea—Methotrexate—urinary bladder cancer	0.00108	0.00108	CcSEcCtD
Cefoxitin—Hypotension—Epirubicin—urinary bladder cancer	0.00106	0.00106	CcSEcCtD
Cefoxitin—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.00105	0.00105	CcSEcCtD
Cefoxitin—Pain—Methotrexate—urinary bladder cancer	0.00104	0.00104	CcSEcCtD
Cefoxitin—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.00103	0.00103	CcSEcCtD
Cefoxitin—Dyspnoea—Epirubicin—urinary bladder cancer	0.00101	0.00101	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000994	0.000994	CcSEcCtD
Cefoxitin—Hypotension—Doxorubicin—urinary bladder cancer	0.000983	0.000983	CcSEcCtD
Cefoxitin—Pain—Epirubicin—urinary bladder cancer	0.000973	0.000973	CcSEcCtD
Cefoxitin—Urticaria—Methotrexate—urinary bladder cancer	0.000966	0.000966	CcSEcCtD
Cefoxitin—Abdominal pain—Methotrexate—urinary bladder cancer	0.000961	0.000961	CcSEcCtD
Cefoxitin—Body temperature increased—Methotrexate—urinary bladder cancer	0.000961	0.000961	CcSEcCtD
Cefoxitin—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000938	0.000938	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.00093	0.00093	CcSEcCtD
Cefoxitin—Urticaria—Epirubicin—urinary bladder cancer	0.000904	0.000904	CcSEcCtD
Cefoxitin—Pain—Doxorubicin—urinary bladder cancer	0.0009	0.0009	CcSEcCtD
Cefoxitin—Abdominal pain—Epirubicin—urinary bladder cancer	0.000899	0.000899	CcSEcCtD
Cefoxitin—Body temperature increased—Epirubicin—urinary bladder cancer	0.000899	0.000899	CcSEcCtD
Cefoxitin—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000895	0.000895	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000861	0.000861	CcSEcCtD
Cefoxitin—Pruritus—Methotrexate—urinary bladder cancer	0.00086	0.00086	CcSEcCtD
Cefoxitin—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000838	0.000838	CcSEcCtD
Cefoxitin—Urticaria—Doxorubicin—urinary bladder cancer	0.000836	0.000836	CcSEcCtD
Cefoxitin—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000832	0.000832	CcSEcCtD
Cefoxitin—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000832	0.000832	CcSEcCtD
Cefoxitin—Diarrhoea—Methotrexate—urinary bladder cancer	0.000832	0.000832	CcSEcCtD
Cefoxitin—Pruritus—Epirubicin—urinary bladder cancer	0.000805	0.000805	CcSEcCtD
Cefoxitin—Diarrhoea—Epirubicin—urinary bladder cancer	0.000778	0.000778	CcSEcCtD
Cefoxitin—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000775	0.000775	CcSEcCtD
Cefoxitin—Vomiting—Methotrexate—urinary bladder cancer	0.000773	0.000773	CcSEcCtD
Cefoxitin—Rash—Methotrexate—urinary bladder cancer	0.000766	0.000766	CcSEcCtD
Cefoxitin—Dermatitis—Methotrexate—urinary bladder cancer	0.000766	0.000766	CcSEcCtD
Cefoxitin—Pruritus—Doxorubicin—urinary bladder cancer	0.000745	0.000745	CcSEcCtD
Cefoxitin—Vomiting—Epirubicin—urinary bladder cancer	0.000723	0.000723	CcSEcCtD
Cefoxitin—Nausea—Methotrexate—urinary bladder cancer	0.000722	0.000722	CcSEcCtD
Cefoxitin—Diarrhoea—Doxorubicin—urinary bladder cancer	0.00072	0.00072	CcSEcCtD
Cefoxitin—Rash—Epirubicin—urinary bladder cancer	0.000717	0.000717	CcSEcCtD
Cefoxitin—Dermatitis—Epirubicin—urinary bladder cancer	0.000717	0.000717	CcSEcCtD
Cefoxitin—Nausea—Epirubicin—urinary bladder cancer	0.000676	0.000676	CcSEcCtD
Cefoxitin—Vomiting—Doxorubicin—urinary bladder cancer	0.000669	0.000669	CcSEcCtD
Cefoxitin—Rash—Doxorubicin—urinary bladder cancer	0.000664	0.000664	CcSEcCtD
Cefoxitin—Dermatitis—Doxorubicin—urinary bladder cancer	0.000663	0.000663	CcSEcCtD
Cefoxitin—Nausea—Doxorubicin—urinary bladder cancer	0.000625	0.000625	CcSEcCtD
